iBio, Inc. (IBIO)
NYSEAMERICAN: IBIO · Real-Time Price · USD
3.480
-0.150 (-4.13%)
At close: Feb 21, 2025, 4:00 PM
3.490
+0.010 (0.29%)
After-hours: Feb 21, 2025, 7:59 PM EST
iBio, Inc. Market Cap
iBio, Inc. has a market cap or net worth of $34.36 million as of February 21, 2025. Its market cap has increased by 2,190.92% in one year.
Market Cap
34.36M
Enterprise Value
32.10M
1-Year Change
2,190.92%
Ranking
Category
Stock Price
$3.48
Market Cap Chart
Since November 16, 2009, iBio, Inc.'s market cap has increased from $27.70M to $34.36M, an increase of 24.06%. That is a compound annual growth rate of 1.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 34.40M | 53.57% |
| Dec 31, 2024 | 22.40M | 1,078.95% |
| Dec 29, 2023 | 1.90M | -52.50% |
| Dec 30, 2022 | 4.00M | -96.66% |
| Dec 31, 2021 | 119.70M | -37.40% |
| Dec 31, 2020 | 191.20M | 2,320.25% |
| Dec 31, 2019 | 7.90M | -43.57% |
| Dec 31, 2018 | 14.00M | -14.63% |
| Dec 29, 2017 | 16.40M | -53.41% |
| Dec 30, 2016 | 35.20M | -18.71% |
| Dec 31, 2015 | 43.30M | -12.17% |
| Dec 31, 2014 | 49.30M | 128.24% |
| Dec 31, 2013 | 21.60M | -27.03% |
| Dec 31, 2012 | 29.60M | 10.04% |
| Dec 30, 2011 | 26.90M | -73.23% |
| Dec 31, 2010 | 100.50M | 298.81% |
| Dec 31, 2009 | 25.20M | -9.03% |
View and export this data all the way back to 2009.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |